| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.52B | 43.31B | 43.01B | 46.91B | 50.01B | 43.61B |
| Gross Profit | 13.57B | 13.35B | 12.92B | 14.64B | 17.32B | 13.70B |
| EBITDA | 3.83B | 3.72B | 3.56B | 4.75B | 6.55B | 3.88B |
| Net Income | 1.98B | 1.92B | 1.67B | 2.26B | 3.53B | 1.85B |
Balance Sheet | ||||||
| Total Assets | 36.75B | 36.02B | 36.42B | 38.89B | 40.26B | 37.07B |
| Cash, Cash Equivalents and Short-Term Investments | 9.32B | 9.42B | 10.06B | 12.60B | 10.64B | 11.62B |
| Total Debt | 1.24B | 1.44B | 817.00M | 2.80B | 4.07B | 5.90B |
| Total Liabilities | 12.21B | 10.76B | 10.40B | 12.30B | 16.78B | 16.59B |
| Stockholders Equity | 24.54B | 25.25B | 26.03B | 26.59B | 23.48B | 20.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.54B | 2.19B | 708.00M | 1.94B | 1.32B |
| Operating Cash Flow | 0.00 | 2.62B | 3.43B | 2.09B | 4.13B | 2.94B |
| Investing Cash Flow | 0.00 | -1.18B | -1.45B | 322.00M | -2.69B | -52.00M |
| Financing Cash Flow | 0.00 | -2.08B | -4.53B | -448.00M | -2.41B | 1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €135.37B | 22.00 | 5.59% | 3.17% | 5.90% | 16.30% | |
73 Outperform | ¥25.02B | 13.21 | ― | 5.00% | 1.23% | 9.96% | |
69 Neutral | ¥72.61B | 15.60 | ― | 3.34% | 28.06% | 19.48% | |
68 Neutral | ¥3.76B | 7.57 | ― | 2.03% | 2.80% | 34.63% | |
67 Neutral | ¥17.59B | 12.78 | ― | 2.41% | 8.52% | 25.85% | |
62 Neutral | ¥210.32B | 55.27 | 2.65% | 3.42% | 2.93% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |